Esophageal Obstruction Due to Food Impaction Treated With Caroid Solution

Schaff, Burnett; McCALLEN, A M

doi:10.1016/s0016-5085(50)80138-5

Cited by 14 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The knowledge that 50,000 units of Actase (the recommended dose is 50,000 to 150,000 units) contains aminute quantity of plasmin (5.1 casein units) t and a small quantity of streptokinase (6,500 units) suggests that it will cause little or no biochemo Actase. The use of the term human fibrinolysin in Heu of human plasmin can be regarded only as unfortunate.…”

Section: Clinical Pharmacology and Therapeuticsmentioning

confidence: 99%

Proteolytic enzymes: a therapeutic evaluation

Sherry

Fleteher

1960

Clin Pharma and Therapeutics

View full text Add to dashboard Cite

A promising development 0/ recent years has been the application of proteolytic enzymes to the therapy of disease in the human. Originally applied directly to the diseased area to efJect a local enzymatic debridement, proteolytic enzyme therapy is now being extended on a systemic basis to widen considerably the scope of its applicability. This report summarizes the current state of knowledge of proteolytic enzymes as therapeutic agents. It indicates those areas where the usefulness of proteolytic enzyme therapy is well established and those areas where the efficacy of such enzyme therapy is less well accepted or under active clinical investigation. Though much has been accomplished already at the clinicallevel, particular stress is placed on the problems which remain to be solved if proper exploitation of this new and exciting area of pharmacology is to be achieved.

show abstract

Section: Clinical Pharmacology and Therapeuticsmentioning

confidence: 99%